IHAM
BNTX icon

Integral Health Asset Management’s BioNTech BNTX Stock Holding History

Integral Health Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,000
Closed -$3.64M – 79
2025
Q1 		$3.64M Sell
40,000
-60,000
-60% -$6.72M 0.39% 62
2024
Q4 		$11.4M Buy
100,000
+50,000
+100% +$5.71M 0.97% 36
2024
Q3 		$5.94M Buy
+50,000
New +$4.6M 0.67% 40
2023
Q3 		– Sell
-36,000
Closed -$3.89M – 71
2023
Q2 		$3.89M Buy
+36,000
New +$4.05M 0.48% 61
2021
Q3 		– Sell
-17,000
Closed -$3.81M – 79
2021
Q2 		$3.81M Buy
+17,000
New +$3.21M 1.05% 38

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Integral Health Asset Management's BNTX Position: Q2 2025 in Review

Integral Health Asset Management sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 40,000 shares — an estimated $3.64M sold.

Integral Health Asset Management first reported a position in BNTX in Q2 2021 and held it in 5 quarters. The position peaked at $11.4M in Q4 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Integral Health Asset Management reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 40,000 BioNTech shares in Q2 2025, an estimated $3.64M.
  • Integral Health Asset Management first reported a position in BioNTech in Q2 2021 and held it in 5 quarters.
  • Integral Health Asset Management's BioNTech position peaked at $11.4M in Q4 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Integral Health Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.